🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy, safety, and tolerab...
Status
Completed
Location
Kessler Institute for Rehabilitation
Start Date
2012-06
Trial ID
NCT01621113
Treatments Being Tested
In this protocol the investigators will test the effect of dalfampridine (a...
Status
Completed
Location
Sleep Disorders Research Program Brigham and Women's Hospital
Start Date
2016-01
Trial ID
NCT02656160
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety, tolerability...
Status
Completed
Location
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center
Start Date
2003-11
Trial ID
NCT00654927
Treatments Being Tested
The purpose of the study is to provide expanded access (compassionate use) ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00994916
Treatments Being Tested
The purpose of this study is to evaluate the role of single dose 4-aminopyr...
Status
Recruiting
Location
Banner University Medical Center
Start Date
2025-04-21
Trial ID
NCT06003166
Treatments Being Tested
Multiple Sclerosis (MS) patients often complain of cognitive fatigue. There...
Status
Completed
Location
London Health Sciences Center and St. Joseph's Heathcare Center (Parkwood)
Start Date
2012-09
Trial ID
NCT01667497
Treatments Being Tested
The purpose of this study is to see if the study drug 4-aminopyridine (4-AP...
Status
Withdrawn
Location
University of Rochester Medical Center
Start Date
2018-10-03
Trial ID
NCT03658408
Treatments Being Tested
Hypothesis: 3,4-Diaminopyridine base (3,4-DAP) improves Lambert-Eaton Myast...
Status
Completed
Location
University of California at Davis
Start Date
2012-01
Trial ID
NCT01511978
Treatments Being Tested
The goal of this clinical trial is to learn what dose of the drug fampridin...
Status
Recruiting
Location
University of California, San Diego
Start Date
2026-05-13
Trial ID
NCT07171203
Treatments Being Tested
Proof-of-concept study on the effects of 10 mg fampridine (oral administrat...
Status
Withdrawn
Location
University of Basel, Transfaculty Research Platform
Start Date
2040-01-01
Trial ID
NCT04516603
Treatments Being Tested